Anna Dolnik

2.3k citations

39 papers · 900 indexed · h-index 15

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
Genetics top 5%
- Chronic Lymphocytic Leukemia Research

Papers in ⓘ

Hematology 23
- Acute Myeloid Leukemia Research 17
- Chronic Myeloid Leukemia Treatments 7
- Multiple Myeloma Research and Treatments 5
Genetics 9
- Chronic Lymphocytic Leukemia Research 5
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4

Co-authors: Lars Bullinger (35 shared papers)Hartmut Döhner (20 shared papers)Konstanze Döhner (14 shared papers)Johannes Bloehdorn (2 shared papers)Stephan Stilgenbauer (3 shared papers)Daniel Mertens (3 shared papers)Eugen Tausch (3 shared papers)Tamara J. Blätte (10 shared papers)
Journals: Blood (12 papers)Blood Advances (4 papers)Leukemia (3 papers)Scientific Reports (2 papers)Haematologica (2 papers)
Partner nations: Germany United States Italy

In The Last Decade

Anna Dolnik

37 papers receiving 896 citations

Peers

Countries citing papers authored by Anna Dolnik

Since Specialization

Citations

This map shows the geographic impact of Anna Dolnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Dolnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Dolnik more than expected).

Fields of papers citing papers by Anna Dolnik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Dolnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Dolnik. The network helps show where Anna Dolnik may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Dolnik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Dolnik Line = papers co-authored together Anna Dolnik links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia Haematologica ·Eugen Tausch, William Close, Anna Dolnik, Johannes Bloehdorn, Brenda Chyla, Lars Bullinger, Hartmut Döhner, Daniel Mertens, Stephan Stilgenbauer	2019	138
2	Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing Blood ·Anna Dolnik, Julia C. Engelmann, Maren Scharfenberger‐Schmeer, Julian Mauch, Sabine Kelkenberg-Schade, Berit Haldemann, Tamara Fries, Jan Krönke, Michael W.M. Kühn, Peter Paschka, Sabine Käyser, Stephan Wolf, Verena I. Gaidzik, Richard F. Schlenk, Frank G. Rücker, Hartmut Döhner, Claudio Lottaz, Konstanze Döhner, Lars Bullinger	2012	112
3	Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information Scientific Reports ·Thomas J. Ettrich, Daniel Schwerdel, Anna Dolnik, Florian Beuter, Tamara J. Blätte, Stefan Schmidt, Nora Stanescu-Siegmund, Jochen Steinacker, Ralf Marienfeld, Alexander Kleger, Lars Bullinger, Thomas Seufferlein, Andreas W. Berger	2019	84
4	Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care Leukemia ·Hartmut Döhner, Anna Dolnik, Lin Tang, John F. Seymour, Mark D. Minden, Richard M. Stone, Teresa Bernal, Haifa Kathrin Al‐Ali, Valeria Santini, Paresh Vyas, C.L. Beach, Kyle J. MacBeth, Barry Skikne, S. Songer, Nora Tu, Lars Bullinger, Hervé Dombret	2018	82
5	Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia Haematologica ·Steffen Hirsch, Tamara J. Blätte, Sarah Grasedieck, Sibylle Cocciardi, A. MAUREEN ROUHI, Mojca Jongen‐Lavrencic, Peter Paschka, Jan Krönke, Verena I. Gaidzik, Hartmut Döhner, Richard F. Schlenk, Florian Kuchenbauer, Konstanze Döhner, Anna Dolnik, Lars Bullinger	2017	65
6	NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML Blood ·Daniel Sasca, Jakub Szybinski, Andrea Schüler, Viral Shah, Jan B. Heidelberger, Patricia S. Haehnel, Anna Dolnik, Oliver Kriege, Eva-Marie Fehr, Wolf Henning Gebhardt, George Reid, Claudia Scholl, Matthias Theobald, Lars Bullinger, Petra Beli, Thomas Kindler	2019	52
7	ProSAP-interacting Protein 1 (ProSAPiP1), a Novel Protein of the Postsynaptic Density That Links the Spine-associated Rap-Gap (SPAR) to the Scaffolding Protein ProSAP2/Shank3 Journal of Biological Chemistry ·Doreen Wendholt, Christina Spilker, Angelika Schmitt, Anna Dolnik, Karl‐Heinz Smalla, Christian Proepper, Juergen Bockmann, Kenji Sobue, Eckart D. Gundelfinger, Michael R. Kreutz, Tobias M. Boeckers	2006	48
8	IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemia Blood ·Annika Scheffold, Billy Michael Chelliah Jebaraj, Eugen Tausch, Johannes Bloehdorn, Paolo Ghia, Anella Yahiaoui, Anna Dolnik, Tamara J. Blätte, Lars Bullinger, Rashmi Priyadharshini Dheenadayalan, Li Li, Christof Schneider, Shih‐Shih Chen, Nicholas Chiorazzi, Sascha Dietrich, Martina Seiffert, Stacey Tannheimer, Hartmut Döhner, Daniel Mertens, Stephan Stilgenbauer	2019	44
9	Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma Nature Communications ·Yuen Lam Dora Ng, Evelyn Ramberger, Stephan Bohl, Anna Dolnik, Christian Steinebach, Theresia Conrad, Sina Müller, Oliver Popp, Miriam Kull, Mohamed Haji, Michael Gütschow, Hartmut Döhner, Wolfgang Walther, Ulrich Keller, Lars Bullinger, Philipp Mertins, Jan Krönke	2022	42
10	Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia Molecular Cancer ·Yanan Zhai, Prashant Singh, Anna Dolnik, Péter Brázda, Nader Atlasy, Nunzio Del Gaudio, Konstanze Döhner, Hartmut Döhner, Saverio Minucci, Joost H.A. Martens, Lucia Altucci, Wout Megchelenbrink, Lars Bullinger, Hendrik G. Stunnenberg	2022	24
11	Deregulated expression of circular RNAs in acute myeloid leukemia Blood Advances ·Susanne Lux, Tamara J. Blätte, Bernhard Gillissen, Antje Richter, Sibylle Cocciardi, Sabrina Skambraks, Klaus Schwarz, Hubert Schrezenmeier, Hartmut Döhner, Konstanze Döhner, Anna Dolnik, Lars Bullinger	2021	22
12	Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients Scientific Reports ·Chris Lauber, Nádia Correia, Andreas Trumpp, Michael A. Rieger, Anna Dolnik, Lars Bullinger, Ingo Roeder, Michael Seifert	2020	19
13	TFE3 activation in a TSC1‐altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms The Journal of Pathology Clinical Research ·Maren Schmiester, Anna Dolnik, Uwe Kornak, Berit M. Pfitzner, Michael Hummel, Denise Treue, Arndt Hartmann, Abbas Agaimy, Veronika Weyerer, Anja Lekaj, Susanne Brakemeier, Robert W. Peters, Robert Öllinger, Sven Märdian, Lars Bullinger, Jana K. Striefler, Anne Flörcken	2020	18
14	Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1) Leukemia ·Tatjana Meyer, Nikolaus Jahn, Stefanie Lindner, Linda Röhner, Anna Dolnik, Daniela Weber, Annika Scheffold, Simon Köpff, Peter Paschka, Verena I. Gaidzik, Dirk Heckl, Sebastian Wiese, Benjamin L. Ebert, Hartmut Döhner, Lars Bullinger, Konstanze Döhner, Jan Krönke	2019	16
15	Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myeloma Blood Advances ·Stephan Bohl, Laura K. Schmalbrock, Imke Bauhuf, Tatjana Meyer, Anna Dolnik, Martin Szyska, Tamara J. Blätte, Sarah Knödler, Linda Röhner, Denise Miller, Miriam Kull, Christian Langer, Hartmut Döhner, Anthony Letai, Frédérik Damm, Dirk Heckl, Lars Bullinger, Jan Krönke	2021	16
16	The leukemogenicity of Hoxa9 depends on alternative splicing Leukemia ·Christiane Stadler, Vegi M. Naidu, Medhanie Mulaw, K E Edmaier, Vijay P.S. Rawat, Anna Dolnik, Lars Bullinger, Bernhard Heilmeier, Leticia Quintanilla-Martı́nez, Karsten Spiekermann, Wolfgang Hiddemann, Konstanze Döhner, Hartmut Döhner, Michaela Feuring‐Buske, Christian Buske	2014	13
17	Sipa1l3/SPAR3 is targeted to postsynaptic specializations and interacts with the Fezzin ProSAPiP1/Lzts3 Journal of Neurochemistry ·Anna Dolnik, Noreen Kanwal, Sarah Mackert, Sonja Halbedl, Christian Proepper, Juergen Bockmann, Michael Schoen, Tobias M. Boeckers, Susanne J. Kühl, Michael J. Schmeißer	2015	12
18	A robust estimation of exon expression to identify alternative spliced genes applied to human tissues and cancer samples BMC Genomics ·Alberto Risueño, Beatriz Rosón, Anna Dolnik, Jesús María Hernández‐Rivas, Lars Bullinger, Javier De Las Rivas	2014	11
19	Telomere-Binding TRF2/MTBP Localization during Mouse Spermatogenesis and Cell Cycle of the Mouse Cells L929 PubMed ·Anna Dolnik, Inna S. Kuznetsova, A.P. Voronin, O. I. Podgornaya	2003	9
20	Protein phosphatase 4 regulatory subunit 2 (PPP4R2) is recurrently deleted in acute myeloid leukemia and required for efficient DNA double strand break repair Oncotarget ·Julia Herzig, Lars Bullinger, Alpaslan Tasdogan, Philipp Zimmermann, Martin Schlegel, Veronica Teleanu, Daniela Weber, Frank G. Rücker, Peter Paschka, Anna Dolnik, Edith Schneider, Florian Kuchenbauer, Florian H. Heidel, Christian Buske, Hartmut Döhner, Konstanze Döhner, Verena I. Gaidzik	2017	9

About Anna Dolnik

Anna Dolnik is a scholar working on Hematology, Genetics, Cancer Research, Molecular Biology and Oncology, having authored 39 papers that have together received 900 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (17 papers), Protein Degradation and Inhibitors (7 papers), Chronic Myeloid Leukemia Treatments (7 papers), Cancer Genomics and Diagnostics (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and RNA Research and Splicing (4 papers). The work is most often cited by research in Hematology (333 citations), Genetics (190 citations), Cancer Research (237 citations), Molecular Biology (564 citations) and Pathology and Forensic Medicine (122 citations). Anna Dolnik has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Lars Bullinger, Hartmut Döhner, Konstanze Döhner, Johannes Bloehdorn, Stephan Stilgenbauer, Daniel Mertens, Eugen Tausch, Tamara J. Blätte, William Close and Jan Krönke. Their work appears in journals such as Blood, Blood Advances, Leukemia, Scientific Reports and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact